Blogs

Latest Blogs

Validating Immunity: How ELISpot Data Shaped the AELIX-003 HIV Cure Trial

We are proud to share our laboratory’s role in a landmark clinical study published in Nature Communications, titled “Safety, immunogenicity and effect on viral rebound…
02 Jul, 2025 |  Blogs
Video

The Next Frontier for CAR T-Cell Therapy: Shifting Gears to Autoimmune Conditions

CAR T-cell therapy has transformed cancer treatment, offering new hope for patients with aggressive B cell malignancies like acute lymphoblastic…
18 Feb, 2025 |  Blogs
Video

Identifying biomarkers of success: Integrated bioanalysis for glioblastoma CAR-T cell clinical trials

Glioblastoma remains one of the most aggressive and treatment-resistant cancers. Standard therapies often fail, leaving patients with limited options.…
18 Oct, 2024 |  Blogs
Video

Allogeneic CAR T cell therapies: A major step forward

In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…
09 Oct, 2024 |  Blogs
Video

A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology

Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…
17 Sep, 2024 |  Blogs
Video

The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers

Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…
05 Sep, 2024 |  Blogs
Video

The STING in the tail: How our own defense mechanisms to infection may be working against us

In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…
29 Aug, 2024 |  Blogs

Quick Links

Talk to our Biomarker Experts